Temporary treatment interruption

OTHER2 trials

Sponsors

University of North Carolina, Chapel Hill

Conditions

HIV (Human Immunodeficiency Virus)HIV/AIDS

Phase 1

The DART DELIVER-02 Study

SuspendedNCT07217379

University of North Carolina, Chapel HillHIV (Human Immunodeficiency Virus)

Start: 2025-10-02End: 2027-02-01Target: 24Updated: 2026-08-18

DELIVER-02: Dual DART treatment with latency reversal in PWH on ART

Active, not recruitingPACTR202511728273171

Start: 2026-01-01Target: 24Updated: 2026-09-14